Fenretinide and fenretinide plus imatinib significantly decreased the number and size of total colonies created from CD34+ CML cells, as demonstrated by colony-forming cell tests performed on clinical specimens. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.